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ABSTR ACT: Increasing evidence suggests that oxysterol-binding protein-related proteins (ORPs) localize at membrane contact sites, which are 
high-capacity platforms for inter-organelle exchange of small molecules and information. ORPs can simultaneously associate with the two apposed 
membranes and transfer lipids across the interbilayer gap. Oxysterol-binding protein moves cholesterol from the endoplasmic reticulum to trans-Golgi, 
driven by the retrograde transport of phosphatidylinositol-4-phosphate (PI4P). Analogously, yeast Osh6p mediates the transport of phosphatidylserine 
from the endoplasmic reticulum to the plasma membrane in exchange for PI4P, and ORP5 and -8 are suggested to execute similar functions in mam-
malian cells. ORPs may share the capacity to bind PI4P within their ligand-binding domain, prompting the hypothesis that bidirectional transport of a 
phosphoinositide and another lipid may be a common theme among the protein family. This model, however, needs more experimental support and does not 
exclude a function of ORPs in lipid signaling.
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Introduction
The main site of lipid synthetic reactions in eukaryotic cells 
is the endoplasmic reticulum (ER). Although lipids lack 
intrinsic motifs specifying their distinct intracellular distri-
butions, each organelle has its characteristic lipid composi-
tion that ensures optimal conditions for membrane-associated 
biochemical reactions and other organelle-specific functions 
such as ion transport and signal transduction. The com-
partmentalization of cells necessitates well-controlled lipid 
fluxes between organelles. Inter-organelle lipid transport 
occurs via three major mechanisms: (1) Movement as con-
stituents of transport vesicles;1 (2) Transfer by lipid binding/
transfer proteins (LTPs), which carry lipids within a hydro-
phobic pocket through the aqueous environment;2,3 and 
(3) Diffusion between closely apposed membrane leaflets. 
A wealth of evidence demonstrates that a substantial por-
tion of the inter-organelle transport of lipids occurs via non-
vesicular mechanisms.3 Of note, LTP-mediated transfer of 
lipid molecules over the narrow gap between closely apposed 
bilayers is envisioned to provide a markedly specific and effi-
cient means of lipid transport.4–11
Oxysterol-binding protein (OSBP) is an LTP identi-
fied in the 1980s as a cytoplasmic high-affinity receptor for 
a variety of oxysterols.12 This ubiquitously expressed protein 
consists of a carboxy-terminal ligand-binding domain and an 
amino-terminal region that contains a pleckstrin homology 
(PH) domain interacting with phosphatidylinositol-
4-phosphate (PI4P) in the trans-Golgi membranes.13–16 
Between these domains, there is a dimerization motif, which 
mediates homodimer formation and heterodimerization with 
the closely related OSBP2/ORP4L,16,17 as well as a sequence 
motif (two phenylalanines in an acidic tract [FFAT]) that 
interacts with ER vesicle-associated membrane protein-
associated proteins (VAPs) (Fig. 1).18 Families of proteins car-
rying an OSBP-related ligand-binding domain (ORD) have 
been identified in virtually all eukaryotic organisms for which 
sequence information is available: Mammals have 12 OSBPL 
genes encoding ORPs,19–21 the zebrafish Danio rerio has 14,22 
Caenorhabditis elegans 4,23 Drosophila melanogaster 4,24 and 
the yeast Saccharomyces cerevisiae 725 OSBP homologue genes 
(Fig. 1), suggesting that the gene products serve fundamental 
and conserved functions in eukaryotic cell physiology.
For a number of years, the nature of the function of ORPs 
remained enigmatic. The suggested functions included control 
of sterol homeostasis, intracellular sterol transport, and poorly 
understood roles in cell signaling and developmental processes. 
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Clues of the physiologic roles of ORPs as we currently under-
stand them were obtained from the seminal observations that 
(1) the PH domain of mammalian OSBP targets the Golgi 
complex;13,14 (2) a yeast ORP called Osh1p localizes at a mem-
brane contact site (MCS), the nucleus–vacuole junction;26 and 
(3) most ORPs carry an FFAT motif that specifies interac-
tion with the ER VAPs.18 These observations led us to propose 
that localization and function at MCSs, where ER membranes 
are closely apposed to other organelle membranes, might be a 
common denominator of the ORPs.27 MCSs are found ubiq-
uitously and occur between the ER and virtually every other 
organelle type, including organelles not engaged in vesicle 
transport, mitochondria, peroxisomes, and cytoplasmic lipid 
droplets. Such membrane junctions execute a multitude of 
functions in lipid syntheses, inter-organelle lipid transport, 
Ca2+ regulation, signaling events, autophagy, mitochondrial 
fission, and organelle partitioning in yeast mitosis.6–11 In the 
past few years, a number of studies adding essential insight into 
the modes of ORP action have been published. In this review, 
I focus on selected key findings suggesting that the function of 
ORPs involves transport of specific lipid ligands over MCSs, 
lipid remodeling in trans over an MCS, or lipid signaling.
Localization of ORPs at Membrane Contact Sites
Membrane-targeting determinants on the ORPs. 
Eight of the mammalian ORPs (OSBP, ORP1, -2, -3, -4, -6, 
-7, and -9) and three yeast OSBP homologues (Osh1p, -2p, 
and -3p) possess upstream of their ORD a short motif desig-
nated FFAT.18 This motif interacts specifically with the major 
sperm protein (MSP) domain of VAPs, type 2 integral proteins 
of the ER.28 Moreover, mammalian ORP5 and -8 carry a 
carboxy-terminal trans-membrane segment that targets the 
ER.29,30 On the other hand, most of the mammalian ORPs 
have a PH domain that is in several cases known to interact 
with phosphoinositides (PIPs) in distinct non-ER organelle 
membranes.31 In addition, ORPs interact with membrane-
associated regulatory proteins, such as the small GTPase Arf1 
in the case of OSBP15,32 and Rab7 in the case of ORP1L.33 
The capacity of ORPs to target two distinct ER and non-ER 
organelle membranes is termed “dual targeting”.
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Figure 1. Structural organization of the ORPs. (A) Schematic diagram of the structure of mammalian and yeast ORPs. In the nomenclature of the 
proteins, L indicates “long” isoforms that contain a PH domain and S indicates “short” isoforms lacking this domain. Mammalian proteins are indicated 
with black, and yeast ones with blue print on the right. PH, pleckstrin homology domain; D, dimerization; L, leucine repeat domains delineated in OSBP 
and ORP4L; FFAT, “two phenylalanines in an acidic tract”; ORD, OSBP-related ligand-binding domain; ANK, ankyrin repeats; TM, trans-membrane 
segment. (B) A model of how OSBP is thought to bridge between ER and trans-Golgi membranes at a contact site (based on Ref. 32). Both OSBP and 
VAPs anchoring it to ER membranes are suggested to operate as dimers. PI4P, phosphatidylinositol 4-phosphate; Arf, the small GTPase ADP-ribosylation 
factor; MSP, major sperm protein domain; VAP, VAMP-associated protein.
ORPs in lipid transport over MCSs 
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Yeast Osh proteins at MCSs. Since the seminal obser-
vation on Osh1p (see Introduction), increasing evidence has 
accumulated for the localization of ORPs at MCSs both in 
yeast and in mammalian cells. Four of the seven yeast Osh 
proteins, namely Osh2p, Osh3p, Osh6p, and Osh7p, are 
enriched in the cortical ER (cER), where the ER forms exten-
sive contacts with the plasma membrane (PM) (Table 1).34,35 
Of note, the yeast VAP orthologues mediating the association 
of Osh2p and Osh3p with the ER, namely Scs2p and Scs22p, 
were found to be among the six genes the disruption of which 
caused disappearence of the cER and disturbed ER functions 
in general.36 While Osh2p and Osh3p (as well as Osh1p) 
carry an FFAT motif-mediating interaction with VAPs and a 
PH domain for targeting non-ER compartments, Osh6p and 
Osh7p lacked these motifs but were still found associated with 
the cER. Likewise, Osh4p, which lacks an FFAT motif and a 
PH domain, was shown to cluster ER- and PM-derived ves-
icles, apparently via two distinct membrane-binding surfaces 
delineated on the protein.34
Mammalian ORPs at organelle interfaces. ORP1L, 
which is highly expressed in the central nervous system and 
in macrophages,37 targets late endosome/lysosome (LE) limit-
ing membranes via interaction with the small GTPase Rab7 
and the ER via VAPs.33 We recently showed by employing 
bimolecular fluorescence complementation (BiFC) that 
ORP1L–VAP complexes in fact localize at ER–LE contacts 
(Table 1), which control the motility and positioning of the LE 
in a sterol-dependent manner.38,39 The closest homologue of 
ORP1, namely ORP2, possesses an FFAT motif but no PH 
domain. When expressed alone, this protein targets lipid drop-
let (LD) surfaces.40 However, complexes of ORP2 with VAP 
decorate ER structures with LD attached to them, suggest-
ing that ORP2 has the capacity to mediate ER–LD interac-
tions.39 Furthermore, we found evidence that the ORP2–VAP 
complexes have the capacity to facilitate the synthesis and to 
inhibit the degradation of cellular triglycerides in hepatoma 
cells, indicating that the ER–LD contacts mediated by these 
proteins execute an important function in the control of neu-
tral lipid metabolism. A further family member, ORP3, which 
is expressed at highest levels in epithelia and lymphatic tis-
sues/leukocytes,41 forms a physical complex with the small 
GTPase R-Ras. Our work in the embryonic kidney cell line 
HEK293 has demonstrated that ORP3 interacts with VAPs 
at the ER and ER–PM contact sites.42 Du et al29 presented 
evidence indicating that ORP5, which is anchored in the ER 
via a trans-membrane segment, interacts with the LE choles-
terol transporter Niemann—Pick C1 protein (NPC1) and may 
reside at ER–LE contact zones; however, the latest report by 
Table 1. Localization and suggested functions of human and yeast ORPs in lipid transport over MCSs.
MAMMALIAN MCS LIPIDS TRANSPORTED REFERENCE(S)
OsBp ER1-trans-golgi Cholesterol, pi4p2 32
ORp4/OsBp2 ? Cholesterol (B) 17
ORp1L ER-LE3 Cholesterol (B) 23, 38, 65
ORp2 ER-Ld4, ER-pM5? Cholesterol 39, 40, 83
ORp3 ER-pM ? 42
ORp6 ? ?
ORp7 ? ?
ORp5 ER-pM
ER-LE?
ps6, pi4p
Cholesterol (in vitro)
43
29
ORp8 ER-pM ps, pi4p 43
ORp9 ER-trans-golgi? Cholesterol (in vitro), pi4p (B) 45, 84
ORp10 ? ps (B) 52
ORp11 trans-golgi-LE7? ? 85
S. cerevisiae
Osh1p nVJ8 Cholesterol (in vitro) 26, 34
Osh2p ER-pM Cholesterol (in vitro) 34
Osh3p ER-pM PI4P (B), cholesterol (in vitro) 34, 51
Osh4p ER-PM? (Golgi, exocytotic vesicles, endosomes) sterols, pi4p, pip29 34, 49, 50, 55, 69, 73, 75
Osh5p ? Cholesterol (in vitro) 34
Osh6p ER-pM ps, pi4p 35, 52, 53
Osh7p ER-pM ps 52
Notes: 1Endoplasmic reticulum; 2Phosphatidylinositol-4-phosphate; 3Late endosome; 4Lipid droplet; 5Plasma membrane; 6Phosphatidylserine; 7Late endosome; 
8Nucleus-vacuole junction; 9Phosphatidylinositol-4,5-bisphosphate; (B) There is evidence for binding of the lipid but whether it is transported by the protein in 
unclear.
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De Camilli and coworkers suggests that ORP5, like its close 
homologue ORP8, rather localizes at ER–PM contacts.43
Importantly, the hallmark study of Mesmin et al32 has 
demonstrated that OSBP can annex together two types of 
giant unilamellar vesicles, one population decorated with 
VAP and the other containing PI4P, thus promoting the 
formation of an MCS in vitro. The authors also showed that 
double overexpression of VAP and OSBP constructs in HeLa 
cells induced extensive ER–Golgi MCSs. The localization of 
ORPs/Osh proteins at MCSs is associated with the observa-
tions that several ORPs are capable of accommodating not 
only one but two distinct types of lipid ligands within their 
ORD and new functional insight sprouting from these find-
ings (see below).
ORPs are Not Exclusively Sterol-Binding Proteins
Structure of the ORD. The ORDs of a number of 
ORPs can accommodate a variety of oxysterols, cholesterol, or 
ergosterol.44–48 Im et al44 reported the high-resolution struc-
ture of the yeast ORP Osh4p complexed with five different 
sterols (cholesterol, ergosterol, 7-, 20-, and 25-hydroxycholes-
terol [25OHC]), revealing a b-barrel-like fold with a lipid-
binding pocket, in which the bound sterol is oriented with its 
3b-hydroxyl group facing the bottom of the cavity. The bound 
sterol stabilizes a closed conformation of a lid consisting of 
a two-stranded b-sheet and three a-helices. The lid-open 
Osh4p was suggested to expose basic amino acid residues near 
the mouth of the ligand cavity that interact with negatively 
charged head groups of membrane lipids, thus facilitating the 
extraction of sterol from the bilayer.
Accommodation of glycerophospholipids within the 
ORD. Raychaudhuri et al49 reported that Osh4p can also 
extract PIP2 from vesicles and mediate significant transfer 
of this lipid in vitro, suggesting that PIP2 could be fully or 
partially inserted into the ligand cavity of Osh4p. The first 
structural evidence for the binding of a PIP or, more gen-
erally, a glycerophospholipid within the ligand cavity of an 
ORP was provided by Saint-Jean et al,50 who determined the 
structure of Osh4p crystallized with PI4P in the ORD cavity. 
Furthermore, they demonstrated that a bound sterol, dehy-
droergosterol (DHE), was readily exchanged for PI4P. The 
authors suggested that the two lipids could be transported by 
Osh4p in opposite directions in cells, sterol from the ER to 
the trans-Golgi and PM and PI4P in the opposite direction. 
Intriguingly, Saint-Jean et al identified at the entrance of the 
ligand cavity a cleft that accommodated the phosphoinositol 
moiety of PI4P, and indicated that amino acid residues lin-
ing this cleft were highly conserved among all ORPs. Further 
proof for liganding of ORPs by glycerophospholipids was pro-
vided by Tong et al,51 who solved the structure of the Osh3p 
ORD with bound PI4P. This study suggested that the ligand 
cavity of Osh3p was too narrow to accommodate bulky sterol 
molecules. The above observations brought up the possibil-
ity that PI4P binding could be a unifying feature of many or 
even all ORPs, and that only a subset of these proteins could 
additionally accommodate sterol ligands.
Maeda et al52 demonstrated that yeast Osh6p and Osh7p 
specifically bind phosphatidylserine (PS) and can extract 
this phospholipid from membranes. The authors crystallized 
Osh6p and modeled PS into the ORD ligand cavity. The head 
group and the unsaturated sn-2 fatty acyl chain were oriented 
toward the entrance of the pocket, while a saturated sn-1 
chain pointed toward the bottom of the cavity. The authors 
found Osh6p to be unable to extract ergosterol from mem-
branes, suggesting that it, similar to Osh3p (see above), may 
be unable to bind sterol ligands. Of importance, the latest 
work by the group of Drin demonstrated that Osh6p can, in 
addition to PS, bind PI4P.53 Interestingly, sequence analyses 
by Maeda et al52 suggested that the mammalian ORP5, -8, 
-9, -10, and -11 belong to the same clade as Osh6p, and found 
that the ORDs of human ORP5 and -10 can in fact extract 
PS from liposomes. Consistently, Chung et al43 identified by 
mass spectrometry PS 36:1 and a PIP bound within the ORD 
of ORP8.
Among the mammalian ORPs, the archetype family 
member OSBP is the first one shown to accommodate either 
sterols or a glycerophospholipid (PI4P) within its ORD.32 
This means that OSBP can interact with PI4P with both its 
PH domain and its ORD. The functional implications of this 
observation are addressed in detail in the following paragraph.
ORPs can Mediate Lipid Transfer Over MCSs
Intracellular sterol transport in yeast. It has been 
known  for a long time that the transport of sterols from 
the yeast  PM to the ER occurs largely via non-vesicular 
mechanisms.54 The study of Raychaudhuri et al49 initally 
suggested that the yeast Osh proteins played a role in this sterol 
transport process (Table 1). However, the first direct evidence 
that ORPs could mediate non-vesicular sterol transport over 
membrane contacts was provided by Schulz et al,34 who 
showed that sterol transport in vitro mediated by yeast Osh4p 
was markedly inhibited by a porous membrane separating the 
donor and acceptor vesicles, suggesting that the transport does 
not rely on diffusible carrier structures. In a recent study, von 
Filseck et al55 demonstrated, using real-time in vitro lipid trans-
port assays, that yeast Osh4p can, as earlier suggested by Saint-
Jean et al,50 indeed transport a sterol against its concentration 
gradient by dissipating the energy of a PI4P gradient. This 
transport is sustained by the PI4P-phosphatase Sac1p, which 
hydrolyzes the transported PI4P in the acceptor compartment.
Bidirectional transport of cholesterol and PI4P by 
mammalian OSBP. A similar mode of transport was reported 
for the mammalian OSBP by Mesmin et al,32 who provided 
elegant evidence that OSBP can tether ER and Golgi mem-
branes and mediate the forward transport of cholesterol 
against its concentration gradient from the ER to trans-Golgi 
(Table 1; Fig. 2A). The transport is suggested to be driven by 
the retrograde transport of PI4P. The authors also showed that 
ORPs in lipid transport over MCSs 
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mutations inhibiting either the VAP or PI4P interaction of 
OSBP markedly impaired its lipid transport function. In the 
model arising from these observations, synthesis of PI4P in 
Golgi membranes and its hydrolysis in the ER by Sac1 sustain 
a gradient of membrane PI4P concentration driving the trans-
port of cholesterol over MCSs mediated by OSBP. The fact 
that PI4P, which is retrogradely transported by the ORD of 
OSBP, also acts as a ligand for its PH domain in Golgi mem-
branes provides an obvious mechanism of autoregulation of the 
OSBP transport function. The high-affinity oxysterol ligand 
of OSBP, namely 25OHC, was shown to inhibit the transport 
function, locking OSBP at Golgi membranes. Of note, the 
role of OSBP in lipid transport is not limited to the direct 
cholesterol/PI4P carrier function suggested above; OSBP was 
also reported to promote recruitment of the ceramide trans-
porter CERT to Golgi sites,56 which most likely represent 
ER–Golgi MCSs.57 The two LTPs act in concert with Nir2, a 
phosphatidylinositol (PI) transfer protein that supplies Golgi 
membranes with PI for the generation of PI4P.58
Role of ORPs in the Generation of Viral Replication 
Organelles
An interesting extension of the above findings on a role of 
OSBP as a lipid transporter over MCSs is its essential role 
in the replication of enteroviruses and the hepatitis C virus 
(HCV). A recent study revealed that the antifungal agent 
itraconazole inhibits enterovirus and HCV replication by tar-
geting OSBP and its close homologue ORP4.59 Consistently, 
? ??????? ????????????? ???? ??? ? ? ????????? ????? ???? ??????? ????????? ??????? ???? ????? ????? ?????? ?? ? ??????? ??? ?? ? ? ? ? ?? ?? ?
Figure 2. Models for the function of ORPs at membrane contact sites (MSCs). (A) OSBP transfers cholesterol (C) within its ligand-binding domain (ORD) 
over MCSs from the ER to trans-Golgi and PI4P in the opposite direction (based on Ref. 32). The phosphatidylinositol 4-phosphate (PI4P) retrogradely 
transported to the ER is hydrolyzed by the phosphatase Sac1 to phoshatidylinositol (PI) and inorganic phosphate. The PI4P gradient between Golgi 
and ER thus drives the forward transport of cholesterol against its concentration gradient. The fact that OSBP is targeted to the Golgi through binding 
of its pleckstrin homology (PH) domain to PI4P provides a mechanism of autoregulation of the process. FFAT, “two phenylalanines in an acidic tract,” 
motif mediating the interaction of OSBP with the VAMP-associated proteins (VAP) in the ER. (B) Models for ORP function as regulators of enzymatic 
or signaling processes at MCSs. An ORP binds a lipidous ligand (L), which regulates the conformation of the protein, allowing it to stimulate at an ER–
plasma membrane contact (a) the activity of an enzyme (E) that is anchored in ER membranes and modifies in trans the structure of lipid substrates in the 
plasma membrane (based on Refs. 74, 75 on yeast Osh3p), or (b) the activation of a signaling component, eg, a small GTPase (G; based on Ref. 45  
on ORP3). X, an activator of the GTPase. The inactive enzyme and GTPase are depicted in green and the active ones in orange. Regulation of the 
processes by the ligand (L) is in the cases of Osh3p and ORP3 hypothetical, and whether L is transported over the contact site is unknown.
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OSBP knockdown and the small molecular antagonist of 
OSBP and ORP4, OSW-1, suppressed enterovirus replica-
tion. OSBP and ORP4 were also identified as targets of the 
minor enviroxime-like compounds, which inhibit enterovirus 
and HCV replication.60 The enteroviral RNA synthesis takes 
place in modified Golgi-derived membrane compartments 
designated “replication organelles”, which are enriched in PI4P. 
Certain virus-encoded proteins enhance phosphatidylinositol 
4-kinase (PI4K) activity in the replication membranes. This 
results in the synthesis of PI4P to recruit OSBP, which trans-
fers cholesterol to the membrane structures.61 Similarly, OSBP 
was shown to act as an effector of PI4K in HCV infection, con-
tributing to cholesterol enrichment of the membranous web, 
which is the HCV replication compartment that arises as an 
extension of the ER.62 Moreover, replication of rhinoviruses 
causing common cold was shown to invariably require OSBP, 
and distinct rhinovirus subtypes also showed some dependence 
on other family members ORP1, -2, -5, -6, -7, -8, -9, -10, 
or -11.63 Even though the role of MCSs in the formation of 
the viral replication organelles has not been addressed in detail, 
the above results (1) suggest that lipid transport over MCSs by 
OSBP and possibly other ORPs may be required for genera-
tion and/or function of these subverted membrane structures, 
and (2) bring up the intriguing possibility of employing ORPs 
as targets for the development of new antiviral therapies.
ORPs in Phosphatidylserine Transport to the Plasma 
Membrane
The study by Maeda et al52 provided convincing data that yeast 
Osh6p and Osh7p, which localize at the cER, are instrumen-
tal for the transport of PS from the ER to the PM. The Osh6p/
Osh7p-mediated transport also occurred at 4°C, consistent 
with a non-vesicular mechanism. Interestingly, the authors 
showed that it was possible to misdirect the flux of PS from 
the ER to the vacuole with a rapamycin-inducible Osh6p–
Vph1p (a trans-membrane protein of the vacuole) complex, 
further supporting a specific function of Osh6p in the trans-
port of PS and the notion that the process most likely involves 
MCSs. The latest report by van Filseck et al53 demonstrates 
that Osh6p can transport PS and PI4P in an exchange-type 
fashion and that the Osh6p-mediated PS transport in yeast 
cells depends on recognition of PI4P by the protein and on the 
presence of Sac1p, which hydrolyzes the counter-transported 
PI4P in the ER. In a concomitant study, Chung et al43 reported, 
based on experiments with HeLa cells and mouse embryonic 
fibroblasts, that ORP5 and ORP8 execute a similar PS/PI4P 
exchange function at ER–PM contacts in mammalian cells. 
These proteins are anchored by a trans-membrane span in 
ER membranes but localize in part at patches associated with 
the cell cortex. By employing the rapamycin-inducible FRB/
FKBP heterodimerization approach, the authors showed that 
physical tethering of the ER to the PM by the ORPs was 
required for the PS/PI4P exchange to occur, demonstrating 
that the transport process occurs at MCSs.
Function of ORP1L at the ER–Late Endosome 
Interface—Lipid Sensor or Transporter
There is substantial evidence to suggest that liganding of 
ORP1L by sterols regulates distinct ER–LE contacts, the 
recruitment of dynein-dynactin motor complexes on the LE, 
and LE tethering mediated by the homotypic fusion and 
protein sorting (HOPS) complex. Depletion of cell cholesterol 
or expression of mutant ORP1L defective in sterol binding 
results in increased ER–LE contacts and a scattered subcellular 
distribution of LE, while liganding of ORP1L by cholesterol 
detaches LE from ER and facilitates recruitment of dynein–
dynactin motor complexes on the LE. This leads to their 
microtubule (–)end-directed motility and clustering/fusion in 
the perinuclear region.38,64,65 However, whether the ER–LE 
contacts mediated by ORP1L and VAP play a role in inter-
organelle lipid transport is thus far unclear. We showed that 
depletion of macrophage ORP1L by RNAi results in a defect 
in the efflux of endocytosed lipoprotein-derived cholesterol,38 
and the data of Kobuna et al23 suggested the involvement of 
ORP1L in the formation of LE intralumenal vesicles. Interest-
ingly, ORP1L was shown to interact with the adenoviral protein 
RIDa, which generates a virus-induced Niemann–Pick C1 
(NPC1) independent pathway for cholesterol transport from 
late endocytic compartments to the ER for esterification.66,67 
ORP1L is essential for this transport process, further imply-
ing that it either acts as a cholesterol carrier or generates dis-
tinct membane contacts over which the transport occurs. To 
conclude, there is extensive evidence that ORP1L functions as 
a sterol sensor that controls ER–LE MCSs and LE motility, 
positioning, and tethering. However, a lipid transporter func-
tion at ER–LE MCSs is also possible.
ORPs and Cell Signaling: Direct Function as 
Constituents of Signaling Complexes or Indirect 
Effects via Organelle Lipid Compositions
Role of OSBP in the control of extracellular-signal-
regulated kinases. A number of reports have provided evi-
dence for the roles of ORPs in cell signaling.42,48,68–70 In 
certain cases, they have been found to associate physically with 
signaling proteins, while on other occasions one can argue 
that ORP family members may affect signaling indirectly via 
effects on organelle lipid compositions. The best example of 
the former is the reported capacity of OSBP to scaffold two 
protein phophatases, namely the serine/threonine phospha-
tase PP2A and the tyrosine phosphatase HePTP, which con-
trol the activity of extracellular signal-regulated kinases.48 The 
cholesterol-bound OSBP was suggested to associate with the 
active phosphatases, while depletion of cholesterol or addi-
tion of 25OHC resulted in dissociation of the complex. These 
findings implied that OSBP forms a functional link between 
the cellular sterol status and mitogenic signaling cascades. 
The relationship between this signaling function and the 
role of OSBP in cholesterol transport from the ER to trans-
Golgi, however, remains unclear. It seems plausible that, 
ORPs in lipid transport over MCSs 
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since 25OHC, which targets OSBP to Golgi membranes, 
dissociates the phosphatase complex, the active complex may 
not be associated with the Golgi or ER–Golgi MCSs but may 
rather occur in the cytosol. Although the above observations 
are highly interesting, it is puzzling that they have not been 
followed up by work from other research groups.
New evidence for ORP3 as a modulator of R-Ras 
signaling. We recently found that ORP3, which associates 
physically with the small GTPase R-Ras, is, in complex with 
its ER anchor VAPA, partially localized at ER–PM MCSs.42 
Both the PM-targeting PH domain and the ER-targeting 
FFAT motif were demonstrated to be required for the capacity 
of ORP3 to activate R-Ras and its downstream signaling tar-
gets Akt and b1-integrins, suggesting that by targeting both 
membrane compartments, putatively at MCSs, ORP3 creates 
a platform for R-Ras activation (Fig. 2B). The lipid ligands of 
ORP3 are thus far unknown, but we find this protein unlikely 
to bind sterols.22 Thus, there is currently no information or 
hypothesis on its putative role as a lipid transporter at the 
ER–PM contacts.
Yeast Osh3p in the control of enzymes at ER–plasma 
membrane junctions. Yeast Osh3p, which localizes in the 
cER, has been assigned functions as a regulator of enzymes 
active at the ER–PM contact sites. Stefan et al71 provided evi-
dence that Osh3p recruits the ER integral PI4-phosphatase 
Sac1p to ER–PM MCSs, where it can access in trans its sub-
strate PI4P at the PM. In this way Osh3p would contribute 
to regulation of the PI4P content of the PM or its specific 
domains, with impacts on PM PIP signaling and vesicle 
transport. Analogously, Tavassoli et al72 reported that Osh3p 
has the capacity to recruit another ER enzyme Opi3p, a phos-
phatidylethanolamine (PE) N-methyltransferase, at ER–PM 
contacts, where it converts plasma membrane PE in trans to 
phosphatidylcholine (PC). These articles on Osh3p provide 
examples of ORP function as modulators of organelle lipid 
composition via mechanisms not involving inter-organelle 
lipid transfer (Fig. 2B). However, the data do not exclude the 
possibility that Osh3p could also act as a lipid transporter over 
the ER–PM MCSs—the ORD of this protein binds PI4P,51 
which could plausibly be a retrogradely transported ligand, 
the other putative lipid ligand(s) being thus far unknown. Of 
note, the findings of Stefan et al71 could also reflect retrograde 
transport of PI4P by Osh3p and hydrolysis of the PIP in cis 
by Sac1p in the ER.
Yeast Osh4p: Lipid Transporter or Signal Transducer
Quite distinct from the suggested role in the bidirectional 
sterol/PI4P transport function suggested by Saint-Jean et al50 
and von Filseck et al,55 the group of Bankaitis has reported 
results implying a signaling function of yeast Osh4p.69 They 
found that a sterol-binding deficient point mutant Osh4Y97F, 
originally characterized by Alfaro et al,73 interferes with 
yeast proliferation due to its enhanced association with the 
trans-Golgi network (TGN) and endosomes. These data 
suggested that sterol binding within the ORD of Osh4p acts 
as a negative regulatory signal that detaches the protein from 
the TGN/endosomal membranes. Whether Osh4p could act 
as both a sterol-dependent signal mediator and a transporter 
of the bound sterol is thus far unclear, but this possibility 
cannot be excluded. The Osh4Y97F-mediated growth arrest 
observed by Mousley et al69 was associated with amino acid 
deficiencies caused by defects in the trafficking of amino acid 
permeases, suppression of gene expression driven by GCN4, 
a transcriptional activator of the general amino acid control 
(GAAC) regulon, and disturbed target of the rapamycin com-
plex 1 (TORC1) signaling. The precise nature of the signal 
generated on TGN/endosomal membranes by Osh4p remains 
enigmatic, and the associated context of interaction partners 
mediating the input from Osh4p to the downstream signal-
ing is unknown. The authors suggested that the signal might 
involve enrichment of sphingolipids in these membranes, an 
idea supported by the study of LeBlanc et al,74 who observed 
sphingolipid defects in Δosh4 cells. In addition to the above 
function, Osh4p was shown to reside on yeast secretory vesi-
cles and to regulate their PI4P content, with impacts on polar-
ized exocytosis.73,75 Moreover, work by the group of Menon 
indicated that the Osh proteins may rather control the dis-
tribution of sterols between lateral membrane domains than 
their inter-organelle transport.76 The above investigations 
do not support a simple function of Osh4p as a sterol/PI4P 
transporter, but provide implications of a more complex role 
of this protein in TGN/endosomal PI4P/sphingolipid signal-
ing or sterol organization in membranes. However, one cannot 
exclude the possibility that the protein may execute more or 
less interconnected transport and signaling functions.
Future Pespectives
Membrane contact sites are currently moving into the focus of 
cell biological research. It is quite obvious that the functional 
interplay of distinct organelles is orchestrated via direct physi-
cal contacts to a much larger extent than previously appreciated. 
Functions of such membrane junctions in the inter-organelle 
flow of small molecules and information, as well as their 
molecular constituents, are being characterized at a rapid 
pace. The concept that MCSs act as high-capacity and high-
specificity platforms of inter-organelle lipid transfer is gaining 
ground, and there is substantial evidence that certain ORPs 
(mammalian OSBP, ORP5, and ORP8; yeast Osh4p, -6p, 
and 7p) play important roles as sterol, PI4P, or PS transport-
ers over MCSs. An attractive hypothesis is that ORPs could 
use the energy deposited in the intracellular gradient of PI4P 
(or possibly other PIPs) to drive the transport of lipids against 
their concentration gradients. Substantial evidence is accu-
mulating in support of this “bidirectional lipid transporter” 
hypothesis. However, further evidence is required, and one 
needs to elucidate how widely this functional hypothesis 
is applicable among the large eukaryotic ORP families. An 
urgent key task is the identification of the endogenous cellular 
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lipid ligands of the remaining ORP family members from 
different organisms. This information will be instrumental in 
further testing of the bidirectional lipid transporter hypoth-
esis. Another crucial line of study will be the identification 
and characterization of the proteomes and functional protein 
complexes located at distinct MCSs and their relationships 
with the inter-organelle bridges formed by ORPs. To place all 
this new molecular information into its physiologic context, 
intense research efforts aimed at understanding the function 
of ORPs in developmental processes, cell fate determina-
tion, metabolism, and signaling in vivo are constantly war-
ranted. Of note, no ORP has thus far been associated with 
ER–mitochondrion contacts, the biogenesis of mitochondria, 
or mitochondrial partition in mitosis. Furthermore, the role 
of this machinery in disease-associated processes such as ER 
stress responses or autophagy has not been addressed. The first 
reports connecting genetic defects of ORPs (OSBPL genes) 
to human disease are beginning to emerge: Mutations in 
OSBPL1A encoding ORP1L were found to be associated with 
extremely low serum high-density lipoprotein (HDL) choles-
terol levels,77 and a frameshift mutation in OSBPL2 encoding 
ORP2 was suggested to cause a form of autosomal dominant 
hearing loss.78,79 Moreover, studies on knock-out mice have 
suggested roles of ORP8 in HDL regulation and of the mac-
rophage protein in atherogenesis,80,81 as well as of ORP4 in 
the postmeiotic differentiation of male germ cells.82 Future 
work on the molecular functions of ORPs in specific cell types 
is required to uncover their roles in human disease and their 
potential as novel therapy targets.
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